jcm-logo

Journal Browser

Journal Browser

Clinical Management of Patients with Cognitive Disorders

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".

Deadline for manuscript submissions: closed (25 September 2024) | Viewed by 5307

Special Issue Editor


E-Mail
Guest Editor
IRCCS Centro Neurolesi Bonino-Pulejo, S.S. 113 Via Palermo, C. da Casazza, 98124 Messina, Italy
Interests: neuropsychology; neurodegenerative disorders; cognitive rehabilitation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cognitive disorders are common symptoms of neurodegenerative and other neurological diseases, such as trauma and stroke. They have a substantial impact on daily life functioning and represent a growing public health concern with significant social and economic implications.

Appropriate management includes the recognition of cognitive deficit presentations and timing throughout the disease course, and the incorporation of different therapeutic strategies (pharmacological and non-pharmacological) to focus on improving quality of life, promoting functional status, limiting residual defects, and on reducing the caregiver's burden. Unfortunately, the therapeutic options for these conditions remain limited and often ineffective.

The goal of this Special Issue is to provide scientific evidence for the latest and most advanced research on management of cognitive disorders, including the potential contribution of new approaches for brain training. We encourage authors to submit original research articles, critical reviews, in-depth reviews.

Dr. Viviana Lo Buono
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cognitive Disorders
  • clinical Management
  • cognition
  • rehabilitation
  • digital Therapeutics
  • quality of life
  • physical exercise training

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Other

14 pages, 988 KiB  
Systematic Review
Risk Factors and Interventions for Suicide in Huntington’s Disease—A Systematic Review
by Alessandro Grimaldi, Isabella Veneziani, Laura Culicetto, Angelo Quartarone and Viviana Lo Buono
J. Clin. Med. 2024, 13(12), 3437; https://doi.org/10.3390/jcm13123437 - 12 Jun 2024
Viewed by 1241
Abstract
Background/Objectives: Huntington’s disease (HD) is an autosomal dominant genetic disorder causing progressive neurodegeneration which, aside from symptomatic therapies for controlling psychological and motor problems, currently has no effective treatment. People who receive this diagnosis often feel disoriented and lost without guidance. Furthermore, [...] Read more.
Background/Objectives: Huntington’s disease (HD) is an autosomal dominant genetic disorder causing progressive neurodegeneration which, aside from symptomatic therapies for controlling psychological and motor problems, currently has no effective treatment. People who receive this diagnosis often feel disoriented and lost without guidance. Furthermore, HD patients are estimated to have a two to seven times greater risk of suicide death compared to the general population. The current review investigates the complex relationship between HD and suicide, seeking to identify key risk factors influencing suicidal ideation and behaviour in affected individuals. Methods: We conducted a systematic review following the PRISMA guidelines. Studies were searched for on the PubMed, Cochrane, and Web of Science databases, and 17 articles met the inclusion criteria. Results: The findings reveal that emotional strain, neuropsychiatric symptoms, and the absence of a cure contribute to heightened suicidal tendencies in HD patients. Critical periods for suicide risk coincide with early symptomatic stages of disease or the successive phase, with the loss of independence impacting on daily functioning. Risk factors associated with HD include a depressive mood, cognitive impairments, and a history of suicide attempts. Conclusions: From a prevention perspective, a comprehensive multidisciplinary and multidimensional approach could enhance the overall well-being of people with HD. In particular, screening for suicidal thoughts in people with HD could mitigate suicide risk. Full article
(This article belongs to the Special Issue Clinical Management of Patients with Cognitive Disorders)
Show Figures

Figure 1

20 pages, 682 KiB  
Systematic Review
The Effects of Transcranial Direct Current Stimulation (tDCS) in HIV Patients—A Review
by James Chmiel, Donata Kurpas, Filip Rybakowski and Jerzy Leszek
J. Clin. Med. 2024, 13(11), 3288; https://doi.org/10.3390/jcm13113288 - 3 Jun 2024
Cited by 1 | Viewed by 1180
Abstract
Introduction: HIV is a severe and incurable disease that has a devastating impact worldwide. It affects the immune system and negatively affects the nervous system, leading to various cognitive and behavioral problems. Scientists are actively exploring different therapeutic approaches to combat these [...] Read more.
Introduction: HIV is a severe and incurable disease that has a devastating impact worldwide. It affects the immune system and negatively affects the nervous system, leading to various cognitive and behavioral problems. Scientists are actively exploring different therapeutic approaches to combat these issues. One promising method is transcranial direct current stimulation (tDCS), a non-invasive technique that stimulates the brain. Methods: This review aims to examine how tDCS can help HIV patients. Searches were conducted in the Pubmed/Medline, Research Gate, and Cochrane databases. Results: The literature search resulted in six articles focusing on the effects of tDCS on cognitive and behavioral measures in people with HIV. In some cases, tDCS showed positive improvements in the measures assessed, improving executive functions, depression, attention, reaction time, psychomotor speed, speed of processing, verbal learning and memory, and cognitive functioning. Furthermore, the stimulation was safe with no severe side effects. However, the included studies were of low quality, had small sample sizes, and did not use any relevant biomarkers that would help to understand the mechanisms of action of tDCS in HIV. Conclusions: tDCS may help patients with HIV; however, due to the limited number of studies and the diversity of protocols used, caution should be exercised when recommending this treatment option in clinical settings. More high-quality research, preferably involving neurophysiological and neuroimaging measurements, is necessary to better understand how tDCS works in individuals with HIV. Full article
(This article belongs to the Special Issue Clinical Management of Patients with Cognitive Disorders)
Show Figures

Figure 1

11 pages, 1754 KiB  
Systematic Review
Cognitive Enhancement Strategies for Older Adults: An Evaluation of Different Training Modalities to Improve Executive Function—A Systematic Review and Meta-Analysis
by Sergi Rodriguez-Rodríguez, Max Canet-Vintró, Sang Ouk Wee, Jacobo Rodríguez-Sanz, Carlos López-de-Celis, Guillermo R. Oviedo, Noé Labata-Lezaun and Albert Pérez-Bellmunt
J. Clin. Med. 2024, 13(5), 1301; https://doi.org/10.3390/jcm13051301 - 25 Feb 2024
Cited by 3 | Viewed by 2374
Abstract
(1) Background: The aging population is expected to triple by 2050. Executive functions decline with age, impacting daily tasks, and this is associated with neurodegenerative diseases. Aerobic and resistance exercises positively affect cognitive function in older adults by influencing growth markers. However, [...] Read more.
(1) Background: The aging population is expected to triple by 2050. Executive functions decline with age, impacting daily tasks, and this is associated with neurodegenerative diseases. Aerobic and resistance exercises positively affect cognitive function in older adults by influencing growth markers. However, the modalities of exercise and the optimal parameters for maximum cognitive benefits remain unclear. (2) Methods: A meta-analysis of randomized clinical trials (RCTs) was conducted. The systematic search was on slowing cognitive decline and performed in the PubMed/MEDLINE and Cochrane Library databases. Articles were included if participants were ≥65 years, healthy, and performing resistance or aerobic exercise, and they were excluded if there was a combination of training and if they have neurological disease or cognitive impairment. (3) Results: The search strategy found a total of 1635 studies. After removing duplicates and assessing the inclusion and exclusion criteria, eight articles were included in the meta-analysis, with a total of 463 healthy older adults analyzed. No significant differences between the intervention groups and the control groups after the aerobic or resistance programs were found. (4) Conclusions: Aerobic exercise interventions improved executive function more than resistance training in older adults, but without statistically significant differences. This can serve as a guide to see, with caution, whether we need a multidisciplinary approach to be more effective in improving the cortical health of older adults. Full article
(This article belongs to the Special Issue Clinical Management of Patients with Cognitive Disorders)
Show Figures

Figure 1

Back to TopTop